Stockhead on MSN
First patient completes dosing in Entropy’s IV psilocin binge eating disorder trial
Special Report: Entropy Neurodynamics has completed dosing of its IV-infused psilocin TRP-8803 for the first patient ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback